Velkommen til hæmatologi
Få de seneste artikler og MEDtalks fra hæmatologi
Nyt fra hæmatologi
ASCO 2026: Sustained MRD and Outcomes in Multiple Myeloma
/ Mattia D' Agostino
EHA 2026: Germline Testing Beyond Family History in AML and MDS
/ Panagiotis Baliakas
Potentiel kurativ genterapi af seglcellesygdom og β-talassæmi i klinisk perspektiv
/ Nina Toft / Jan Andreasen
AML highlights
AML Insights – November Update: What’s New in the Field
/ Amanda Feldballe Bernholm / Jan Andreasen
Nordic AML Insights – November Update
/ Amanda Feldballe Bernholm / Jan Andreasen
AML Insights – July-August Update: What’s New in the Field
/ Amanda Feldballe Bernholm / Jan Andreasen
Nordic AML Insights – July-August Update
/ Amanda Feldballe Bernholm / Jan Andreasen
AML Insights – June Update: What’s New in the Field
/ Jan Andreasen
Seneste magasin fra hæmatologi
Onkologi/Hæmatologi • Nr. 15 • 2025
- PD-L1 Positive Triple-Negative Breast Cancer - Toward a New Standard of Care
- EGFR-Mutated Lung Cancer – A New Treatment Breakthrough
- Lymphoma – Tattoo Ink May Increase the Risk
EHA 2026: Increased Risk of Psychotropic Drug Use Observed in Patients with Mastocytosis
/ Maren Poulsgaard Jørgensen






























